key: cord-0759030-28t38ajy
authors: Zarei, Fariba; Jalli, Reza; Iranpour, Pooya; Sefidbakht, Sepideh; Soltanabadi, Sahar; Rezaee, Maryam; Jahankhah, Reza; Manafi, Alireza
title: Differentiation of chest CT findings between influenza pneumonia and COVID-19: Interobserver agreement between radiologists
date: 2021-05-11
journal: Acad Radiol
DOI: 10.1016/j.acra.2021.04.010
sha: 7329b08931d19c2497cd2a7bff6802f7522e6565
doc_id: 759030
cord_uid: 28t38ajy

OBJECTIVES: To investigate the chest CT and clinical characteristics of COVID-19 pneumonia and H1N1 influenza, and explore the radiologist diagnosis differences between COVID-19 and influenza. MATERIALS AND METHODS: This cross-sectional study included a total of 43 COVID-19-confirmed patients (24 men and 19 women, 49.90 ± 18.70 years) and 41 influenza-confirmed patients (17 men and 24 women, 61.53 ± 19.50 years). Afterwards, the chest CT findings were recorded and three radiologists recorded their diagnoses of COVID-19 or of H1N1 influenza based on the CT findings. RESULTS: The most frequent clinical symptom in patients with COVID-19 and H1N1 pneumonia were dyspnea (96.6%) and cough (62.5%), respectively. The CT findings showed that the COVID-19 group was characterized by GGO (88.1%), while the influenza group had features such as GGO (68.4%) and consolidation (66.7%). Compared with the influenza group, the COVID-19 group was more likely to have GGO (88.1% vs. 68.4%, p = 0.032), subpleural sparing (69.0% vs. 7.7%, p <0.001) and subpleural band (50.0% vs. 20.5%, p = 0.006), but less likely to have pleural effusion (4.8% vs. 33.3%, p = 0.001). The agreement rate between the three radiologists was 65.8%. CONCLUSION: Considering similarities of respiratory infections especially H1N1 and COVID-19, it is essential to introduce some clinical and para clinical modalities to help differentiating them. In our study we extracted some lung CT scan findings from patients suspected to COVID-19 as a newly diagnosed infection comparing with influenza pneumonia patients.

A cluster of pneumonia-infected patients of unexplained etiology appeared in December 2019, known as coronavirus disease 2019 in China (1, 2). A total of 131,580,761 COVID-19confirmed cases and 2,862,510 death cases had been reported by the World Health Organization (WHO) up to April 04, 2021 (3) (4) (5) (6) (7) (8) (9) . Considering the growing number of infected and dead cases, the early diagnosis of novel coronavirus has become a matter of utmost urgency.

Even though reverse transcriptase-polymerase chain reaction (RT-PCR) is the reference standard tool to confirm the diagnosis of COVID-19 pneumonia, a large number of falsenegative/positive RT-PCR results have recently been observed (10, 11) , making the diagnosis rather challenging. Chest CT is currently considered as one of the best methods for early diagnosis which contributes to distinguishing the disease severity, and prognosis of COVID-19 infection (12) .

It is notable that there are several types of respiratory infectious diseases like COVID-19 and H1N1 pneumonia that their chest CT characteristics may differ (13) . Accordingly, when assessing COVID-19, one must note that it shares common etiologies with and occurs in the same season as do influenza viruses (14) . Influenza virus infections are widespread worldwide and cause a high rate of morbidity and mortality (15) . They are divided into four groups (A, B, C, and D), with epidemics of seasonal flu due to influenza A and B (16) . H1N1 is an influenza A virus subtype that contributes to respiratory infections and has generated two pandemics in the last century (17, 18) .

Additionally, given some identical clinical symptoms between H1N1 and COVID-19 pneumonia (19) , it is essential for radiologists to clarify the differences between the two respiratory tract viruses on the basis of radiological manifestations. Therefore, we made an effort to compare the differences between the chest CT findings for H1N1 virus infection and those of COVID-19 in order to provide some guidance for their differential diagnoses. Moreover, another aim of the present study was to assess the interobserver variability between chest radiologists in the evaluation of chest CT scans in patients suspected to COVID-19 infection.

In this cross-sectional and multi-center study, acute respiratory distress syndrome (ARDS) patients suspected to COVID-19 and H1N1 pneumonia were screened. We included all confirmed COVID-19 cases who were admitted from March 1 to July 20 at the isolation ward of Ali Asghar, Faghihi, and Namazi Hospitals of Shiraz University of Medical Sciences, Shiraz, Iran.

Based on the positive results by real-time RT-PCR, patients were divided into COVID-19 (n = 43) and H1N1 (n = 41) groups. Chest CT was carried out for the diagnosis of pneumonia. All patients undergone chest CT within the first 24 hours' admission time. The study was performed in compliance with the principles of the Declaration of Helsinki and obtained the approval of the Ethics Committee of Shiraz University of Medical Sciences, Shiraz, Iran (IR.SUMS.REC.1399.120).

The informed consent was waived because this study was retrospective and thus posed no potential risk to patients.

All patients underwent scanning with the following scanners: 128-MDCT Philips Ingenuity (Philips healthcare, United States), 2-MDCT Siemens (Somatorn Volume Zoom, Siemens, Forchheim, Germany), 4-MDCT GE (Bright Speed, GE Healthcare, Milwaukee, WI), and 2-MDCT Siemens (Somatorn Definition, Siemens, Forchheim, Germany) with 120-130 kvp, 7-250 mAs, tubal current 119-515, Pitch 1.2-1.6, slice thickness 0.625-1.2 mm, and reconstruction thickness of 1-5. All patients were in supine position, performing a breath-hold after inhalation. The scanning range was from bilateral apex to base.

Two radiologists with more than 5 years' experience in chest imaging analyzed all CT images independently. If there was any inconsistency, they reached an agreement through discussion, presenting scientific arguments. A third radiologist (25 years of experience in pulmonary imaging diagnosis) reviewed all CT findings for confirmation.

The predominant patterns seen on CT images were classified into three major categories: lung, bronchial, and pleural changes. Each major category was divided into subcategories. Lung changes were classified into the following nine subcategories: ground-glass opacities (GGO;

increased attenuation without obscuration of the underlying lung vessels), consolidation (homogeneous increased intensity of lung parenchyma with obscuration of the underlying vessels), crazy paving (GGO with septal thickening), reverse halo (central GGO surrounded with more dense consolidation), tree-in-bud pattern (centrilobular nodules with a linear branching pattern), centrilobular nodule, solid nodule (well defined and >3mm), subpleural sparing (Subpleural Lines. These 5-to 10-cm-long curvilinear opacities are found within 1 cm of the pleura and parallel the chest wall. They are most frequent in the posterior portions of the lower lobes and remain unchanged on prone scans. They probably represent an early phase of lung fibrosis and should be distinguished from a similar line that is seen as a result of atelectasis in the dependent portion of the lungs in normal individuals. Subpleural lines are most often seen in patients with asbestosis and, less commonly, IPF.), subpleural band (Parenchymal bands are non-tapering linear opacities, 2 to 5 cm in length, that extend from the lung to contact the pleural surface. These fibrotic bands can be distinguished from vessels and thickened septa by their length, thickness, course, absence of branching, and their association with regional parenchymal distortion. Parenchymal bands are frequently seen in asbestosis, IPF, and sarcoidosis.). Bronchial changes were classified into four subcategories: air bronchogram (an air-filled image of bronchus in lung lesions), bronchiectasis (an irreversible abnormal dilatation of the bronchial tree), air trapping (refers to retention of excess gas ("air") in all or part of the lung; Specially during expiration, either as a result of complete or partial airway obstruction or as a result of local abnormalities in pulmonary compliance.) and bronchus distortion. Pleural changes were classified into two subcategories: thickening of the pleura and pleural effusion.

Distribution of the lung lesions was classified as predominantly peripheral (involving mainly the peripheral region comprising one-third of the lung), central (involving mainly the central region comprising two-thirds of the lung), or peribronchovascular pattern (along with bronchovascular bundle) and diffuse. Each side of the lung was divided (from top to bottom) into three zones: the upper zone (above the carina), the middle zone (from the carina to the inferior pulmonary vein), and the lower zone (below the inferior pulmonary vein). Each zone was then divided into two areas: the anterior area (the area before the vertical line of the midpoint of the diaphragm in the sagittal position) and the posterior area (the area after the vertical line of the midpoint of the diaphragm in the sagittal position). Finally, each lung was divided into 12 zones and the degree of involvement in each lung zone was scored as follows: a score of 0 denoted no involvement; 1, < 25% involvement; 2, 25% to less than 50% involvement; 3, 50% to less than 75% involvement; and 4, ≥ 75% involvements. Scores were recorded and summed for each lung zone, with a maximum possible score of 48.

To perform statistical analysis of the data, the SPSS Statistics 23.0 software (SPSS Inc., Chicago, Illinois, USA) was used. The distribution of data normality was examined by the Kolmogorov-Smirnov test. Moreover, numerical variables were expressed as mean ± standard deviation (SD) and were analyzed by means of the Independent sample t-test/Mann-Whitney U test.

Categorical variables were reported by counts and percentages and evaluated by χ 2 test/Fisher's exact tests. Pairwise agreement between the radiologists were determined by kappa coefficient. A value of P<0.05 was considered statistically significant.

The comparison of demographic, clinical, and laboratory features of the patients infected with COVID-19 and H1N1 pneumonia is shown in Table 1 respectively, while the most common symptoms in influenza patients were cough (62.5%), dyspnea (37.5%) and chills (35.3%). Among the clinical symptoms, cough (P = 0.017), dyspnea (P <0.001) and fatigue (P <0.001) were significantly higher in COVID-19 patients. Meanwhile, chills (P = 0.007), hemoptysis (P = 0.045) and orthopnea (P = 0.045) were higher in influenza patients than in those with COVID-19. About 32% of COVID-19 and 29% of influenza patients were shown to have comorbidities, of which diabetes mellitus and ischemic heart disease were the most common, followed by hypertension. Diabetes mellitus (6/3, P = 0.016) and hypertension Of all 84 cases examined by radiologists, the agreement rate between the three radiologists was 65.8%. Also, all three radiologists recorded their diagnoses on 72 patients, of whom 50 yielded similar diagnoses wherein 33 (39.3%) were identified as COVID-19 and 15 (17.9%) as H1N1 pneumonia ( Table 3) . The H1N1 or COVID-19 diagnosis of each radiologist is given in Table 3 . As shown in Table 4 , the degree of agreement between the diagnoses by either radiologist was significant for the pairwise condition (P <0.001). The values for the degree of agreement (kappa) between the first and second radiologists, the first and third, and the second and third radiologists were 0.419, 0.584, and 0.587, respectively.

As a global health warning introduced by WHO, the widespread COVID-19 pandemic has begun to turn into a new challenge with regard to determining the early diagnosis, isolation, and optimal treatment (2, 20-22). RT-PCR as a laboratory technique and confirmed one is not empty of false-negative reports according to numerous reasons (23) . Therefore, in those highly suspicious patients with negative RT-PCR results, thin-section CT features could be considered as paramount guidance (10, 24, 25) . On the other hand, according to seasonal climate changes, respiratory tract viruses such as influenza and respiratory syncytial viruses tend to involve bronchus, lung parenchyma, and also pleura.

Given the overlapping of clinical manifestations and laboratory findings of COVID-19 and H1N1 pneumonia (14) , the present study compared the chest CT and clinical features of patients infected with SARS-CoV-2 and H1N1 to see what exactly are their differences. It was found that COVID-19 patients had more GGO, subpleural sparing, and also subpleural bands, whereas patients with influenza developed more consolidation and pleural effusions manifestations.

However, no significant difference was detected in terms of CT scores between the two groups.

Considering laboratory data, leukocytosis was more common in H1N1 group, although COVID-19 patients showed significantly higher body temperatures in the course of their disease. Also, COVID-19 patients were clinically wearier and more dyspneic than H1N1 ones and had more cough regardless of lung involvement distribution.

Focusing on common areas of lung involvements, peripheral tendency and multiple lesions pattern have been shown to be the most frequent CT features in COVID-19 patients with prevalence of 83.3% and 81%, respectively, in the present study. These results are inconsistent with previous coronavirus infection surveys like SARS, specially reported in recent studies (3, 4) .

Also, according to the studies by Koo et al. and Miller et al. (26, 27) , patients with influenza, especially H1N1 types, are more prone to the lung lower-lobe involvement as witnessed in the present study. They also showed that consolidation, as a common finding in patients with H1N1 pneumonia, had a higher frequency in lower segments of the lung than in those of COVID-19 patients (51.3% versus 23.8%, respectively) (14) . GGO and consolidation are two prevalent findings in chest CT of patients with bacterial pneumonia that commonly are seen significantly in both COVID-19 and influenza patients as well. However, this study revealed that COVID-19 patients had higher rates of GGO than patients with influenza . The pattern of GGO involvement was also significantly different from the more peripheral trend of injury in COVID-19 patients.

Each of the above-mentioned findings determines and reflects nothing by itself and does not contribute to diagnosing or treating the disease. Rather, they are a combination of some CT features and laboratory data which might better help us to decide whether a certain patient is suspected of COVID-19 or H1N1 pneumonia. The factors that persuade us to consider the patients as COVID-19 include the presence of peripheral and multiple GGO, presence of subpleural sparing and subpleural band, absence of pleural effusion, and lower lob consolidations. Other findings in CT images such as crazy paving sign and bronchiectasis were found in Zhilan et al. (28) to be significantly different in the two groups. In this study, contrarily these two features, besides Atoll sign (reversed halo sign-central ground glass opacity surrounded by denser consolidation of crescentic shape-forming more than three-fourth a circle or complete ring of at least 2 mm in thickness all presented in high resolution CT) (29), air trapping, and air bronchogram, had no significant difference regarding their distribution patterns.

Despite some differences in CT findings of the two groups, the CT score that determines the final outcome of this diagnostic modality was not significantly different. However, this difference was shown to be significant in a recent study on patients with COVID-19 and H1N1 pneumonia (6 versus 15, respectively) (28) . This discrepancy is thought to be the result of our small sample size for the two groups.

In the present study, we compared three radiologists' diagnostic impressions on patients' CT scans with the aim of obtaining a unique concept that would provide a standard reporting language, thereby making a more accurate and relevant diagnosis in patients suspected of COVID-19. By means of interobserver agreement between radiologists in the present study, we will be more able to connect to physicians who provide the same approach and diagnosis. The current results showed that there is a relatively good agreement between expert chest radiologists about the report of CT scans among suspected COVID-19 patients. In the present study, of all 84 cases examined by radiologists, the agreement rate (measure of agreementkappa) between the three radiologists was 65.8%. The degree of agreement about the diagnoses of either radiologist was significant for a pairwise condition. Overall, due to the infectious nature of influenza and COVID-19 diseases and their similarities of lung involvement in both diseases, a definite diagnosis on suspected patients is very hard. Therefore, chest radiologists need some unique clues to distinguish and impute net diagnosis on viral pneumonia patients as well. As a critical issue worldwide, early diagnosis, isolation, and on-time treatment for patients infected by COVID-19 viral pneumonia is highly vital and need a standard agreement between radiologists globally (30). Debray et al. investigated the observer agreement between eight physicians out of two junior radiologists, two thoracic and two general senior radiologists and two emergency physicians. They found a good Kappa coefficient between all readers (31) . Also, in another study by Byrne et al. (32) , they used the Radiological Society of North America (RSNA) expert consensus guidelines to assess the interobserver variability and agreement between chest radiologists diagnosing suspected COVID-19 pneumonia patients. They showed a good interobserver agreement among expert chest radiologists ruling in suspected patients, especially in case of false-negative RT-PCR tests.

Regarding impact of COVID-19 pandemic on all varieties of patients globally, diagnose and isolate viral respiratory infections such as H1N1 influenza have not been convenient. Indeed, performing high resolution chest CT scan for all patients according to their conditions was difficult. Besides these strengths, our study had some limitations due to the small sample size and low number of radiologists included for reporting CT scans. Moreover, we did not use the Radiological Society of North America (RSNA) expert consensus guidelines to compare reports by the radiologists. Furthermore, CT findings could not be related with the severity of symptoms, the onset of disease, and the final prognosis due to lack of available clinical data. On the other hand, we did not evaluated chance of co-infection in our study individual that could be biased our results. In our study COVID-19 patients received more doses of antiviral drugs than patients with H1N1 influenza that should be affect resolving lung involvements in such patients; so, for future studies we recommend much more group equalization to reach the more reliable findings.

The present study showed some significant differences between the thin-cut CT scan features of patients infected with COVID-19 and influenza A virus. A number of common features such as GGO, subpleural sparing and subpleural band were found to be more prevalent in COVID-19 patients, while pleural effusion and consolidation had higher prevalence in individuals with H1N1 influenza. Not only were the peripheral zones of lung more affected in COVID-19

patients, but also the pattern of lung involvement was in the order of multiple lesions in these patients. Meanwhile, H1N1 influenza showed a great inclination to injure lower-lobe segments of the lungs. With respect to the interobserver agreement, we found a good Kappa coefficient between our chest radiologists and concluded if there is a standardized reporting system for radiologists to diagnose the suspected patients, we will obtain an optimal net diagnosis without any delay during this worldwide pandemic.

The authors declare that they have no conflict of interests.

The author(s) received no financial support for the research, authorship, and/or publication of this article. Values are expressed as number and percent for categorical variables and, mean and standard deviation for continuous ones. 

The role of cytokine profile and lymphocyte subsets in the severity of coronavirus disease 2019 (COVID-19): A systematic review and meta-analysis. Life sciences

Laboratory findings of COVID-19 infection are conflicting in different age groups and pregnant women: a literature review. Archives of medical research

A novel coronavirus from patients with pneumonia in China

A novel coronavirus genome identified in a cluster of pneumonia cases-Wuhan

A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster

Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. The lancet

Importation and human-tohuman transmission of a novel coronavirus in Vietnam

Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia

Coronavirus disease 2019 (COVID-19): a perspective from China

Chest CT for typical 2019-nCoV pneumonia: relationship to negative RT-PCR testing

False-positive COVID-19 results: hidden problems and costs. The Lancet Respiratory Medicine

Coronavirus disease (COVID-19): spectrum of CT findings and temporal progression of the disease

COVID-19 pneumonia: CT findings of 122 patients and differentiation from influenza pneumonia

Comparison of hospitalized patients with acute respiratory distress syndrome caused by covid-19 and H1N1

Estimates of global seasonal influenza-associated respiratory mortality: a modelling study

Influenza Virus-Host Co-evolution. A Predator-Prey Relationship?

Pandemic preparedness and response-lessons from the H1N1 influenza of

A year of terror and a century of reflection: perspectives on the great influenza pandemic of 1918-1919

Influenza and COVID-19 coinfection: Report of six cases and review of the literature

Coronavirus disease 2019 (COVID-19): situation report

Laboratory features of severe vs. non-severe COVID-19 patients in Asian populations: a systematic review and meta-analysis

Clinical and Laboratory Findings on the Differences Between H1N1 Influenza and Coronavirus Disease-2019 (COVID-19): Focusing on the Treatment Approach

Negative nasopharyngeal and oropharyngeal swabs do not rule out COVID-19

CT manifestations and clinical characteristics of 1115 patients with coronavirus disease 2019 (COVID-19): A systematic review and meta-analysis

Correlation Between Low-Dose Chest Computed Tomography and RT-PCR Results for the Diagnosis of COVID-19: A Report of 27,824 Cases in Tehran

Radiographic and CT features of viral pneumonia

CT of viral lower respiratory tract infections in adults: comparison among viral organisms and between viral and bacterial infections

A Comparison of Clinical and Chest CT Findings in Patients With Influenza A (H1N1) Virus Infection and Coronavirus Disease (COVID-19)

Chest imaging using signs, symbols, and naturalistic images: a practical guide for radiologists and non-radiologists

Imaging features of coronavirus disease 2019 (COVID-19): evaluation on thin-section CT

Observer agreement and clinical significance of chest CT reporting in patients suspected of COVID-19. medRxiv

RSNA expert consensus statement on reporting chest CT findings related to COVID-19: interobserver agreement between chest radiologists